Immunopathogenesis of atopic dermatitis

Immunology and Allergy Clinics of North America

Volumn 22, Issue 1, 2002, Pages 73-90

  Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 5; PIMECROLIMUS; TACROLIMUS;

ANAPHYLAXIS; ATOPIC DERMATITIS; CELLULAR IMMUNITY; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; TH2 CELL;

EID: 0036170368     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(03)00070-5     Document Type: Review

References (87)

1. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen
2. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis
3. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells
4. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis
5. Allergen sensitization through the skin induces systemic allergic responses
6. Treatment of children with atopic dermatitis (AD) with 1% SDZ ASM 981 cream
7. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial
8. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis
9. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis
10. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis
11. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis
12. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration
13. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis
14. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family
15. Identifying genes predisposing to atopic eczema
16. IL-4 induces the intracellular expression of the alpha chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells
17. Mechanisms of eosinophil-associated inflammation
18. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
19. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis
20. In vivo expression of IL-12 and IL-13 in atopic dermatitis
21. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
22. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
23. Tacrolimus (FK506): New treatment approach in superantigen-associated diseases like atopic dermatitis?
24. T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells
25. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
26. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma
27. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: A potential role in the modulation of IgE synthesis
28. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI
29. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis
30. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families
31. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis
32. Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis
33. Chemical mediators in atopic dermatitis: Involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis
34. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells
35. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
36. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis
37. Clinical and immunologic variables in skin of patients with atopic eczema and either positive or negative atopy patch test reactions
38. Modulation of the atopy patch test reaction by topical corticosteroids and tar
39. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21
40. Atopic dermatitis: New insights and opportunities for therapeutic intervention
41. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies
42. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production
43. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: Evidence for a new group of allergens
44. The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis
45. Atopic dermatitis
46. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy
47. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90)
48. Mast cell-T cell interactions
49. Treatment of allergic asthma with monoclonal anti-IgE antibody: rhuMAb- E25 Study Group
50. CTACK, a skin-associated chemokine that preferentially attracts skin- homing memory T cells
51. Chemokines and allergic disease
52. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
53. Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions
54. IgE regulation and roles in asthma pathogenesis
55. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis
56. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506)
57. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis
58. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis: Implications for sustained dendritic cell activation in the skin
59. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity
60. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens
61. Tacrolimus: A new topical immunomodulatory therapy for atopic dermatitis
62. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
63. The role of lymphocytes in allergic disease
64. Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes
65. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen
66. Differences in antigen-specific T-cell responses between infants with atopic dermatitis with and without cow's milk allergy: Relevance of Th2 cytokines
67. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren
68. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: A comparison with asthmatic and nonasthmatic control subjects
69. Determinants of systemic manifestations of food allergy
70. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis
71. Role of infection in atopic dermatitis
72. Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism
73. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice
74. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis
75. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis
76. In vivo expression of cytokine receptor mRNA in atopic dermatitis
77. Evidence for increased expression of eotaxin and monocyte chemoattractant protein (MCP)-4 mRNA expression in acute versus chronic atopic dermatitis
78. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
79. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis
80. Autoallergy: A pathogenetic factor in atopic dermatitis?
81. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis
82. T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis
83. Antigen presenting cells in allergy
84. Role of inhalant allergens in atopic dermatitis
85. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood
86. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes
87. Enhanced expression of eotaxin and CCR 3 in atopic dermatitis